Crossosoma bigelovii
Crossosoma bigelovii · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Crossosoma bigelovii is a botanical species of significant interest due to its diverse range of bioactive compounds. Research into this plant has identified several key chemicals, including ajmalicine, eugenin, matairesinol, and noreugenin. When processed as an organic solvent extract, these constituents can be effectively isolated for further study. Preliminary investigations have highlighted the plant's potential cytotoxic activities against various cellular models. Understanding these chemical properties is essential for exploring the plant's broader pharmacological applications.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Crossosomataceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Crossosoma bigelovii is a distinctive plant species known for its unique botanical features. Within various ecological circles, it is frequently referred to by the common name Bigelow's crossosoma. Many enthusiasts and field researchers also recognize the plant as the Ragged rockflower. These dual names highlight the different ways the species is identified across various regions. Understanding these common terms can help gardeners and botanists more easily locate this specific wildflower in the wild.
Sources: Catalogue of Life (COL)
Taxonomy
Crossosoma bigelovii is a unique botanical specimen belonging to the vast kingdom Plantae. Within this diverse kingdom, the plant is classified under the class Equisetopsida. It further resides in the order Crossosomatales, showcasing its specific evolutionary lineage. As a member of the family Crossosomataceae, it displays specialized characteristics shared by its relatives. Finally, this species is defined by its placement within the distinct genus Crossosoma.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Crossosomatales |
| Family | Crossosomataceae |
| Genus | Crossosoma |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Crossosoma bigelovii maintains a widespread presence across the diverse landscapes of Northern America. Its natural range extends significantly southward into Mexico, encompassing both the northeastern and northwestern regions of the country. Within the United States, the plant is firmly established throughout the Southwestern territories. It can be found thriving in the arid environments of Arizona, California, and Nevada. This broad distribution highlights the species' ability to adapt to various ecological niches across these regions.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Crossosoma bigelovii is characterized by its distinct growth form as a shrub. This plant remains entirely self-supporting as it matures within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Crossosoma bigelovii has emerged as a significant subject of pharmacological interest due to its potent cytotoxic properties. Through the process of cytotoxicity-guided fractionation, researchers have successfully isolated several bioactive compounds from its organic solvent extracts. These findings include the discovery of a new strophanthidin glycoside alongside two unique 2-methylchromone glycosides. Beyond simple toxicity, the study revealed that these strophanthidin glycosides also demonstrate an ability to inhibit HIF-1 activation. This research marks a pioneering step in understanding the phytochemical potential of the Crossosomataceae family.
Compounds
Crossosoma bigelovii is a plant species that has become a subject of interest due to its diverse phytochemical profile. Through cytotoxicity-guided fractionation of its organic solvent extract, several key bioactive compounds have been identified. The plant contains the indole alkaloid ajmalicine as well as the chromones eugenin and noreugenin. Furthermore, the chemical makeup includes important lignans such as matairesinol and secoisolariciresinol. This comprehensive discovery marks a significant step in understanding the bioactive potential of the Crossosomataceae family.
Conditions
Crossosoma bigelovii produces bioactive phytochemicals that exhibit both cytotoxic and HIF-1alpha inhibitory properties. Through cytotoxicity-guided fractionation, researchers identified specific compounds such as a new strophanthidin glycoside and various 2-methylchromone glycosides. The plant's strophanthidin glycosides are particularly notable for their ability to inhibit HIF-1 activation. This inhibitory effect is scientifically linked to the specific glycosylation of the genin within these compounds. Consequently, the chemical profile of Crossosoma bigelovii serves as a significant source of these dual-action biological agents.
Preparations
Crossosoma bigelovii is prepared as an organic solvent extract to facilitate the discovery of bioactive compounds. Through cytotoxicity-guided fractionation of this specific extract, researchers identified a new strophanthidin glycoside and two new 2-methylchromone glycosides. This preparation method also allowed for the isolation of several known substances, including eugenin, ajmalicine, and various lignans. The resulting phytochemicals from the extract were further investigated to understand their biological properties. Ultimately, using an organic solvent extract of this plant provided the first published study of the bioactive components within the Crossosomataceae family.